New-onset rheumatic immune-mediated inflammatory diseases following SARS-CoV-2 vaccinations until May 2023: a systematic review

A Nune, V Durkowski, SS Pillay, B Barman, H Elwell… - Vaccines, 2023 - mdpi.com
A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-
mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking.
Therefore, we investigated the demographics, management, and prognosis of new R-IMIDs
in adults following SARS-CoV-2 vaccinations. A systematic literature search of Medline,
Embase, Google Scholar, LitCovid, and Cochrane was conducted. We included any English-
language study that reported new-onset R-IMID in adults following the post-COVID-19 …

New-onset rheumatic immune-mediated inflammatory diseases following SARS-CoV-2 vaccinations until May 2023: a systematic review.

S Venkatachalam - 2023 - rwt.dspace-express.com
A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-
mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking.
Therefore, we investigated the demographics, management, and prognosis of new R-IMIDs
in adults following SARS-CoV-2 vaccinations. A systematic literature search of Medline,
Embase, Google Scholar, LitCovid, and Cochrane was conducted. We included any English-
language study that reported new-onset R-IMID in adults following the post-COVID-19 …
以上显示的是最相近的搜索结果。 查看全部搜索结果